Basic Study
Copyright ©The Author(s) 2024.
World J Nephrol. Sep 25, 2024; 13(3): 99105
Published online Sep 25, 2024. doi: 10.5527/wjn.v13.i3.99105
Table 1 Number of subjects enrolled for microarray profiling
Groups
Kidney conditions
Group
Urine samples
Group 1T2DM patients without kidney diseaseDiabetic control 13
Group 2T2DM patients with kidney diseaseDiabetic nephropathy5
Membranous nephropathy 5
IgA nephropathy2
Group 3Healthy subjects without T2DM or kidney diseaseHealthy control6
Table 2 Demographic and anthropometric details of subjects enrolled in the study
Serial number
Variable
Diabetic control
Diabetic nephropathy
Membranous nephropathy
IgA nephropathy
Healthy control
P value
1Sample size (n)1305050206NA
2Age (yr), mean ± SD45.11 ± 7.6547.11 ± 1251 ± 3.849 ± 1.4146 ± 10.790.04
3Gender (male/female)8/53/24/12/03/3NA
4Duration of DM (yr), mean ± SD10± 6.086 ± 52.4 ± 25.12 ± 6.9NA0.06
5BMI (kg/m2), mean ± SD24 ± 3.6424 ± 3.6426.6 ± 623 ± 5.2326 ± 7.040.09
6Medical conditionDM or DM & HTN bothDM or DM & HTN bothDM or HTN or DM & HTN bothIgA nephropathyNANA
Table 3 Table displaying housekeeping miRNAs and their mean expression intensity in urinary exosomes across five kidney conditions (control and disease)
ID
Transcript ID
Healthy control
Diabetic control
Diabetic nephropathy
Membranous nephropathy
IgA nephropathy
20536748has-mir-44792.0366672.0246152.041.931.985
20537225hsa-mir-57032.5366672.1730772.852.432.715
20534637hsa-mir-320a2.2952.5584622.0262.5622.495
20535940hsa-mir-320d-23.7783334.1853853.653.5363.37
20504391hsa-miR-6389.0266678.64307798.7629.205
20536665hsa-mir-44174.1833334.3784623.9323.5043.97
20536810hsa-mir-45302.9966672.8915382.8862.4682.525
20536248hsa-mir-31532.5616673.0338462.2422.532.58
20522537hsa-miR-57879.419.2184629.2288.3868.77
20518446hsa-miR-39212.0452.0769232.462.121.395
20536956hsa-mir-47222.782.6423082.7682.3582.49
20536702hsa-mir-44492.1783331.7915382.692.3642.925
20537581hsa-mir-68362.7016672.5284622.5662.2722.025
20515578hsa-miR-3157-3p2.0716672.4838461.7722.2561.44